These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35550148)

  • 1. Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia.
    Giannetti MP; Godwin G; Weller E; Butterfield JH; Castells M
    J Allergy Clin Immunol; 2022 Nov; 150(5):1225-1227. PubMed ID: 35550148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
    Sordi B; Vanderwert F; Crupi F; Gesullo F; Zanotti R; Bonadonna P; Crosera L; Elena C; Fiorelli N; Ferrari J; Grifoni F; Sciumè M; Parente R; Triggiani M; Palterer B; Mecheri V; Almerigogna F; Santi R; Di Medio L; Brandi ML; Iorno ML; Ciardetti I; Bencini S; Annunziato F; Mannarelli C; Pieri L; Guglielmelli P; Mannelli F; Vannucchi AM
    J Allergy Clin Immunol; 2023 Feb; 151(2):485-493.e11. PubMed ID: 36309122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis.
    Mateja A; Wang Q; Chovanec J; Kim J; Wilson KJ; Schwartz LB; Glover SC; Carter MC; Metcalfe DD; Brittain E; Lyons JJ
    J Allergy Clin Immunol; 2022 Mar; 149(3):1010-1017.e10. PubMed ID: 34425177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia.
    Luskin KT; White AA; Lyons JJ
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2235-2242. PubMed ID: 33744473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
    Polivka L; Madrange M; Bulai-Livideanu C; Barete S; Ballul T; Neuraz A; Greco C; Agopian J; Brenet F; Dubreuil P; Burdet C; Lemal R; Tournilhac O; Terriou L; Launay D; Bouillet L; Gourguechon C; Damaj G; Frenzel L; Meni C; Bouktit H; Collange AF; Gaudy-Marqueste C; Gousseff M; Le Mouel E; Hamidou M; Neel A; Ranta D; Jaussaud R; Guilpain P; Canioni D; Molina TJ; Bruneau J; Lhermitte L; Garcelon N; Javier RM; Pelletier F; Castelain F; Retornaz F; Cabrera Q; Zunic P; Gourin MP; Wierzbicka-Hainaut E; Viallard JF; Lavigne C; Hoarau C; Durieu I; Heiblig M; Dimicoli-Salazar S; Torregrosa-Diaz JM; Soria A; Arock M; Lortholary O; Bodemer C; Hermine O; Rossignol J;
    J Allergy Clin Immunol; 2024 Jan; 153(1):349-353.e4. PubMed ID: 37633651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
    Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G
    Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.
    Lyons JJ; Greiner G; Hoermann G; Metcalfe DD
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1964-1973. PubMed ID: 35597543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary alpha tryptasemia is not associated with specific clinical phenotypes.
    Chollet MB; Akin C
    J Allergy Clin Immunol; 2022 Feb; 149(2):728-735.e2. PubMed ID: 34174297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
    Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.
    Glover SC; Carter MC; Korošec P; Bonadonna P; Schwartz LB; Milner JD; Caughey GH; Metcalfe DD; Lyons JJ
    Ann Allergy Asthma Immunol; 2021 Dec; 127(6):638-647. PubMed ID: 34400315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia.
    Thomas EG; Thomas DJ
    Immunol Allergy Clin North Am; 2023 Aug; 43(3):553-568. PubMed ID: 37394259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
    Shin H; Lyons JJ
    Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.
    Valent P; Hoermann G; Bonadonna P; Hartmann K; Sperr WR; Broesby-Olsen S; Brockow K; Niedoszytko M; Hermine O; Chantran Y; Butterfield JH; Greiner G; Carter MC; Sabato V; Radia DH; Siebenhaar F; Triggiani M; Gülen T; Alvarez-Twose I; Staudinger T; Traby L; Sotlar K; Reiter A; Horny HP; Orfao A; Galli SJ; Schwartz LB; Lyons JJ; Gotlib J; Metcalfe DD; Arock M; Akin C
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3010-3020. PubMed ID: 37572755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mastocytosis and related entities: a practical roadmap.
    Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
    Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome.
    Butterfield J; Weiler CR
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2533-2541. PubMed ID: 32142966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System.
    Waters AM; Park HJ; Weskamp AL; Mateja A; Kachur ME; Lyons JJ; Rosen BJ; Boggs NA
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2424-2435.e5. PubMed ID: 35032694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
    Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.
    Wu R; Lyons JJ
    Curr Allergy Asthma Rep; 2021 May; 21(5):33. PubMed ID: 33970354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation.
    Butterfield JH
    Int Arch Allergy Immunol; 2020; 181(1):43-50. PubMed ID: 31722348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
    Ravi A; Butterfield J; Weiler CR
    J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.